Other languages Precipio, Inc.

Equities

PRPO

US74019L6020

Market Closed - Nasdaq Other stock markets 02:00:00 28/06/2024 am IST			5-day change	1st Jan Change
4.97 ^USD	-1.91%		-3.68%	-23.54%

14/05	Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
19/04	Precipio, Inc. announced that it expects to receive $0.5 million in funding	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/03
Precipio, Inc. and Cardinal Health Sign Distribution Agreement for Its HemeScreen®? Portfolio of Molecular Assays for Cancer	06/02
Sector Update: Health Care Stocks Slipping Late Afternoon	18/01
Sector Update: Health Care Stocks Edge Down Wednesday Afternoon	18/01
Precipio Signs Distribution Deal in Japan, Gets First Order; Shares Rise	17/01
Precipio, Inc. Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan	17/01
Precipio, Inc. Announces Board Changes	02/01
Precipio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Precipio Says Lower Product Revenue Needed to Achieve Cash Flow Breakeven	25/23/25
Precipio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	12/23/12
End in sight for U.S. insider trading case over healthcare leaks	01/23/01
Precipio's Omnia?? Methodology Enables Diagnosis of MDS with Peripheral Blood Instead of Bone Marrow Biopsy	14/23/14
Precipio, Inc. Enters into Collaboration with Prestigious New York-Based Institution to Develop Revolutionary Brain Tumor Panel Using Hemescreen Technology	13/23/13
Precipio Prices $2 Million Registered Direct Offering, Concurrent Private Placement	08/23/08
Precipio, Inc.'s Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology	22/23/22
Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	13/23/13
Precipio Signs Another HemeScreen™? Customer	04/23/04
Precipio Files $50 Million Mixed Shelf	17/23/17
Precipio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Precipio, Inc.

Equities

PRPO

US74019L6020

Other languages

Filters